Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $8.80

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]

Related Keywords

Canada , , Commonwealth Equity Services , Nasdaq , Royal Bank , Schulhoff Co , Pyxis Oncology Inc , Sg Americas Securities , Cetera Advisors , Acadian Asset Management , Jefferies Financial Group , Pyxis Oncology , Get Free Report , Financial Group , Equity Services , Asset Management , Get Free , Pyxis Oncology Daily ,